Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization

Anne K. Van Horne, G. Wright Bates, Randal D. Robinson, Nancy J. Arthur, Anthony M. Propst

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Low-dose hCG supplementation was administered at the start of ovarian stimulation, concomitantly with recombinant FSH (rFSH) in GnRH antagonist cycles, and these were compared with GnRH-a cycles that used rFSH alone. The low-dose hCG group had similar implantation and pregnancy rates but had significantly reduced rFSH requirements, allowing for an average cost savings of $600 per cycle.

Original languageEnglish (US)
Pages (from-to)1010-1013
Number of pages4
JournalFertility and sterility
Volume88
Issue number4
DOIs
StatePublished - Oct 2007
Externally publishedYes

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization'. Together they form a unique fingerprint.

Cite this